Rachael Snow, MD
Vascular Surgery · Idaho Falls, IDNPI 1578925780
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,695 of the $4,089 with a category attached, or 65.9%. 15 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 39.4% of the total. Reporting peaked in 2024 at $2,026 and has fallen 92.9% since, to $145 in 2025.
Across 72 payments — averaging $56.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Johnson & Johnson$654
- Medtronic$421
- Boston Scientific$355
- Penumbra, Inc.$302
- Integra Lifesciences Corporation$196
- plus $550 from 9 others
What the payments were for
- Travel & lodging$1,39434%
- Food & beverage$2,69566%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 8 | $1,612 |
| Johnson & Johnson | 16 | $654 |
| Medtronic | 9 | $421 |
| Boston Scientific | 10 | $355 |
| Penumbra, Inc. | 8 | $302 |
| Integra Lifesciences Corporation | 2 | $196 |
| Smith+Nephew | 6 | $185 |
| Lemaitre Vascular, Inc. | 3 | $132 |
| Tactile Systems Technology Inc | 2 | $62 |
| Pfizer | 3 | $58 |
| Endologix LLC | 1 | $32 |
| Cardiovascular Systems Inc. | 1 | $26 |
| Exact Sciences | 1 | $25 |
| KCI USA, Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Endoprosthesis$1,516
- XARELTO$337
- CODMAN CERTAS$152
- CUSA CLARITY$152
- DURAGEN DURAL GRAFT MATRIX$152
- DURASEAL EXACT SPINAL SEALANT SYSTEM$152
- HAKIM$152
- ENDURANT IIS$141
- Penumbra System$108
- VARITHENA$106
- RESTOREFLOW$106
How this compares
$4,089 in reported general payments places this provider in the 65th percentile of 28 vascular surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 45 | $592 |
| Atorvastatin Calcium | 35 | $317 |
| Cilostazol | 14 | $244 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Idaho Falls
- Warren AlbrechtIdaho Falls$3K
- Laurie KuestnerIdaho Falls$2K
- Elliot AdamsTwin Falls$99K
- Michael TullisMeridian$45K
- Kenneth MadsenBoise$11K
- Louis ZhangBoise$7K
- Matthew LowCoeur D Alene$6K
- Alexis GrahamBoise$6K
- Vikram PalkarBoise$6K
- Christopher WardCoeur D Alene$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.